BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses

Area of Science:

• Epigenetics and Gene Regulation
• Hematopoiesis
• Immunology

Background:

• Bromodomain and extra-terminal (BET) domain proteins, including BRD4, are epigenetic regulators involved in transcription.
• BET/BRD4 inhibitors show therapeutic potential in cancer and inflammation, but BRD4's role in normal hematopoiesis and immunity is unclear.
• Understanding BRD4's function in normal physiological processes is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the biological role of BRD4 in normal hematopoiesis and macrophage inflammatory responses.
• To elucidate the mechanisms underlying BRD4's function, particularly its role in super-enhancer (SE) formation and epigenetic plasticity.

Main Methods:

• Conditional knockout (KO) mouse models for Brd4 analysis.
• Hematopoietic stem cell and progenitor development assays.
• Macrophage differentiation and lipopolysaccharide (LPS)-induced inflammatory response assays.
• Chromatin immunoprecipitation sequencing (ChIP-seq) for genome-wide BRD4 occupancy and SE analysis.

Main Results:

• BRD4 is essential for hematopoietic stem cell expansion and progenitor development.
• BRD4 plays a limited role in macrophage development and LPS-induced inflammatory responses.
• BRD4 occupies a broad range of the macrophage genome and is involved in SE formation.
• Macrophages lacking BRD4 form alternative, BRD4-independent SEs, compensating for BRD4 loss and retaining inflammatory responses.

Conclusions:

• BRD4 exhibits context-dependent functions, being critical for hematopoiesis but less so for macrophage inflammation.
• Epigenetic regulation by BRD4 demonstrates plasticity, with compensatory mechanisms like alternative SE formation maintaining cellular functions.
• These findings highlight the complexity of BRD4 regulation and its implications for therapeutic strategies.